Brakewood Harold Eugene

CBO Brakewood buys 5.25K shares of IMRX at $4.76; stock down 47.6% from 52-week high as cluster buy emerges.

Harold Eugene Brakewood, Chief Business Officer, purchased 5,250 shares at $4.76 on 2026-01-16, more than doubling his stake from 5,800 to 11,050 shares (+90.5%). The timing coincides with material headwinds: the stock trades 47.6% below its 52-week high of $9.26, has declined 17.9% over 30 days, and the company reported zero quarterly revenue with a net loss of $14,964,875 and negative full-year results. However, this buy is reinforced by a cluster pattern—4 other insiders also purchased within the past 14 days—suggesting coordinated conviction at current levels. Brakewood's prior trade at IMRX on 2025-06-20 delivered a +256.3% 90-day return, establishing a track record of successful timing at this specific ticker, though his earlier 2024-03-22 buy declined 45.1%, illustrating that prior success is not guaranteed to repeat in a company burning cash.

CBO Harold Eugene Brakewood buys 1.9K shares of IMRX at $2.53 amid cluster pattern; stock up 90.9% in 30 days but insider's prior IMRX buy in 2024 returned -29.9% at 30d.

Harold Eugene Brakewood, Chief Business Officer, purchased 1,900 shares at $2.53 on 2025-06-20, expanding his position from 3,900 to 5,800 shares (a +48.7% increase relative to pre-transaction holdings). The timing occurs within a cluster of 4 other insider buys in the past 14 days, suggesting coordinated buying activity. However, the company's fundamentals remain deeply challenged: latest quarter revenue is $0.00, net income stands at $-15,046,132.00, and annual revenue growth is -100.0%. Critically, Brakewood's own trading history at this ticker shows poor outcomes: his prior buy on 2024-03-22 produced a 30-day return of -29.9% and 90-day return of -45.1%, indicating a zero 90-day win rate at this security. The recent 30-day and 90-day stock gains (+90.9% and +79.3% respectively) reflect price recovery from severe lows, but Brakewood's documented history suggests persistence in accumulating a distressed-fundamentals asset without demonstrated timing accuracy.